Bnp Paribas Asset Management Holding S.A. Oric Pharmaceuticals, Inc. Transaction History
Bnp Paribas Asset Management Holding S.A.
- $38.6 Billion
- Q3 2025
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 548 shares of ORIC stock, worth $7,173. This represents 0.0% of its overall portfolio holdings.
Number of Shares
548Holding current value
$7,173% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
157Shares Held
105MCall Options Held
35.1KPut Options Held
173K-
Nextech Invest, Ltd. Zurich, V87.16MShares$93.8 Million13.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA6.73MShares$88.1 Million6.03% of portfolio
-
Vr Adviser, LLC New York, NY6.6MShares$86.4 Million11.96% of portfolio
-
Viking Global Investors LP6.57MShares$86 Million0.22% of portfolio
-
Nextech Invest Ag5.29MShares$69.2 Million7.95% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $518M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...